Michael S. Diamond, MD, PhD, Robert D. Schreiber, PhD, and Wayne M. Yokoyama, MD, lead a team of investigators working to develop new immune-based therapies for cancer, infectious disease, autoimmunity and immunodeficiency in the newly named Bursky Center for Human Immunology and Immunotherapy at Washington University School of Medicine.

$10 million gift creates Bursky Center for Human Immunology and Immunotherapy

Washington University School of Medicine in St. Louis has received a $10 million gift to support research that harnesses the immune system to fight cancer, infectious diseases, and disorders caused by autoimmunity and immune deficiencies. The gift from Andrew M. and Jane M. Bursky will advance cutting-edge work at the newly named Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs.
Researchers have identified a potential way to prevent chronic urinary tract infections, a common infection primarily caused by E. coli (shown above). Vaccinating mice against a key protein that E. coli use to latch onto the bladder and cause UTIs reduces severe disease, according to researchers at Washington University School of Medicine in St. Louis. (Image: Scott Hultgren and John Heuser)

Researchers identify protein critical in causing chronic UTIs

Researchers have identified a potential way to prevent chronic urinary tract infections (UTIs). Their research points to a key protein that bacteria use to latch onto the bladder and cause UTIs, according to scientists at Washington University School of Medicine in St. Louis. Vaccinating mice against the protein reduces the ability of bacteria to cause severe disease.
Older Stories